First Cancer Patient Receives mRNA Melanoma Vaccine In New Clinical Trial
When enquiry into mRNA vaccinum was ramped up and they were thrust into the glare in the relentless fight against COVID-19 , meditation began as to how the invention could impact other expanse of music . Now , another turgid milepost has been reached to that end , with the first patient role in the Phase II trial of the BioNTech mRNA cancer vaccine receiving their first Cupid’s disease . The BNT111 treatment will be combined with an existing immunotherapy drug and aims to battle a specific type of advanced malignant melanoma ....